SNTI - Senti Biosciences, Inc.
1.01
-0.130 -12.871%
Share volume: 262,125
Last Updated: 04-23-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.14
-0.13
-0.11%
Summary score
39%
Profitability
35%
Dept financing
37%
Liquidity
58%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.68%
Return on assets
-18.97%
Return on sales
-23431.77%
Return on invested capital
-34.94%
Total debt ratio
55.63%
Debt ratio change over timeo
-2.23%
Current Ratio
4.57%
Quick Ratio
6.31%
Cash Position Ratio
2.98%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-27.02%
Return on sales
-84709.09%
Return on invested capital
0%
Total debt ratio
75.98%
Debt ratio change over timeo
0%
Current Ratio
2.46%
Quick Ratio
0%
Cash Position Ratio
1.78%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-28.81%
Return on sales
-84709.09%
Return on invested capital
0%
Total debt ratio
89.09%
Debt ratio change over time
0%
Current Ratio
1.67%
Quick Ratio
0%
Cash Position Ratio
1.18%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-35.53%
Return on assets
-61.32%
Return on sales
13738.27%
Return on invested capital
10.14%
Total debt ratio
-223.33%
Debt ratio change over time
-2.23%
Current Ratio
-19.65%
Quick Ratio
-20.58%
Cash Position Ratio
-11.69%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SNTI | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -20.68% | 0% | 5.97% | 8.91% |
| Return on assets | -18.97% | 2.97% | 3.34% | 2.04% |
| Return on sales | -23431.77% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | -34.94% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 55.63% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -2.23% | 14.34% | 187.33% | 9.75% |
| Dept financing | 15% | 27% | 43% | 13% |
| Current Ratio | 2.46% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.78% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 21% | 17% | 25% |
| Short-term ratios | SNTI | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -27.02% | 3.27% | 4.7% | 1.36% |
| Return on sales | -84709.09% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 75.98% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 46% | 25% | 18% | 10% |
| Current Ratio | 2.46% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.78% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 32% | 41% | 61% |